Publication
Discovery of a new small-molecule inhibitor of p53–MDM2 interaction using a yeast-based approach
dc.contributor.author | Leão, Mariana | |
dc.contributor.author | Pereira, Clara | |
dc.contributor.author | Bisio, Alessandra | |
dc.contributor.author | Ciribilli, Yari | |
dc.contributor.author | Paiva, Ana M. | |
dc.contributor.author | Machado, Neuza | |
dc.contributor.author | Palmeira, Andreia | |
dc.contributor.author | Fernandes, Miguel X. | |
dc.contributor.author | Sousa, Emília | |
dc.contributor.author | Pinto, Madalena | |
dc.contributor.author | Inga, Alberto | |
dc.contributor.author | Saraiva, Lucília | |
dc.date.accessioned | 2023-02-10T15:04:40Z | |
dc.date.available | 2023-02-10T15:04:40Z | |
dc.date.issued | 2013 | |
dc.description.abstract | The virtual screening of a library of xanthone derivatives led us to the identification of potential novel MDM2 ligands. The activity of these compounds as inhibitors of p53–MDM2 interaction was investigated using a yeast phenotypic assay, herein developed for the initial screening. Using this approach, in association with a yeast p53 transactivation assay, the pyranoxanthone (3,4-dihydro-12- hydroxy-2,2-dimethyl-2H,6H-pyrano[3,2-b]xanthen-6-one) (1) was identified as a putative small molecule inhibitor of p53–MDM2 interaction. The activity of the pyranoxanthone 1 as inhibitor of p53–MDM2 interaction was further investigated in human tumor cells with wild-type p53 and overexpressed MDM2. Notably, the pyranoxanthone 1 mimicked the activity of known p53 activators, leading to p53 stabilization and activation of p53- dependent transcriptional activity. Additionally, it led to increased protein levels of p21 and Bax, and to caspase-7 cleavage. By computational docking studies, it was predicted that, like nutlin-3a, a known small-molecule inhibitor of p53–MDM2 interaction, pyranoxanthone 1 binds to the p53-binding site of MDM2. Overall, in this work, a novel small-molecule inhibitor of p53–MDM2 interaction with a xanthone scaffold was identified for the first time. Besides its potential use as molecular probe and possible lead to develop anticancer agents, the pyranoxanthone 1 will pave the way for the structure-based design of a new class of p53–MDM2 inhibitors. | pt_PT |
dc.description.version | info:eu-repo/semantics/publishedVersion | pt_PT |
dc.identifier.citation | Leão, M., Pereira, C., Bisio, A., Ciribilli, Y., Paiva, A. M., Machado, N., ... & Saraiva, L. (2013). Discovery of a new small-molecule inhibitor of p53–MDM2 interaction using a yeast-based approach. Biochemical Pharmacology, 85(9), 1234-1245. | pt_PT |
dc.identifier.doi | 10.1016/j.bcp.2013.01.032 | pt_PT |
dc.identifier.uri | http://hdl.handle.net/10400.13/5027 | |
dc.language.iso | eng | pt_PT |
dc.peerreviewed | yes | pt_PT |
dc.publisher | Elsevier | pt_PT |
dc.relation | Strategic Project - LA 6 - 2011-2012 | |
dc.relation | Strategic Project - UI 4040 - 2011-2012 | |
dc.relation | USING YEAST CELL-BASED SYSTEMS FOR FUNCTIONAL AND MOLECULAR STUDIES OF P53 FAMILY ISOFORMS: SCREENING FOR SMALL-MOLECULE MODULATORS | |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | pt_PT |
dc.subject | Xanthone derivatives | pt_PT |
dc.subject | Inhibitor of p53–MDM2 interaction | pt_PT |
dc.subject | Computational docking | pt_PT |
dc.subject | Yeast-based assays | pt_PT |
dc.subject | Antitumor activity | pt_PT |
dc.subject | . | pt_PT |
dc.subject | Faculdade de Ciências Exatas e da Engenharia | pt_PT |
dc.title | Discovery of a new small-molecule inhibitor of p53–MDM2 interaction using a yeast-based approach | pt_PT |
dc.type | journal article | |
dspace.entity.type | Publication | |
oaire.awardTitle | Strategic Project - LA 6 - 2011-2012 | |
oaire.awardTitle | Strategic Project - UI 4040 - 2011-2012 | |
oaire.awardTitle | USING YEAST CELL-BASED SYSTEMS FOR FUNCTIONAL AND MOLECULAR STUDIES OF P53 FAMILY ISOFORMS: SCREENING FOR SMALL-MOLECULE MODULATORS | |
oaire.awardURI | info:eu-repo/grantAgreement/FCT/6820 - DCRRNI ID/PEst-C%2FEQB%2FLA0006%2F2011/PT | |
oaire.awardURI | info:eu-repo/grantAgreement/FCT/6817 - DCRRNI ID/PEst-OE%2FSAU%2FUI4040%2F2011/PT | |
oaire.awardURI | info:eu-repo/grantAgreement/FCT//SFRH%2FBD%2F64184%2F2009/PT | |
oaire.awardURI | info:eu-repo/grantAgreement/FCT/5876-PPCDTI/PTDC%2FSAU-FCF%2F100930%2F2008/PT | |
oaire.citation.endPage | 1245 | pt_PT |
oaire.citation.issue | 9 | pt_PT |
oaire.citation.startPage | 1234 | pt_PT |
oaire.citation.title | Biochemical Pharmacology | pt_PT |
oaire.citation.volume | 85 | pt_PT |
oaire.fundingStream | 6820 - DCRRNI ID | |
oaire.fundingStream | 6817 - DCRRNI ID | |
oaire.fundingStream | 5876-PPCDTI | |
person.familyName | Fernandes | |
person.givenName | Miguel Xavier | |
person.identifier.ciencia-id | ED1D-3C7A-467C | |
person.identifier.orcid | 0000-0002-1840-616X | |
person.identifier.rid | A-4373-2013 | |
person.identifier.scopus-author-id | 35466972500 | |
project.funder.identifier | http://doi.org/10.13039/501100001871 | |
project.funder.identifier | http://doi.org/10.13039/501100001871 | |
project.funder.identifier | http://doi.org/10.13039/501100001871 | |
project.funder.identifier | http://doi.org/10.13039/501100001871 | |
project.funder.name | Fundação para a Ciência e a Tecnologia | |
project.funder.name | Fundação para a Ciência e a Tecnologia | |
project.funder.name | Fundação para a Ciência e a Tecnologia | |
project.funder.name | Fundação para a Ciência e a Tecnologia | |
rcaap.rights | openAccess | pt_PT |
rcaap.type | article | pt_PT |
relation.isAuthorOfPublication | 8dab9a0d-f44a-4d2d-b9b1-7b3145162ca3 | |
relation.isAuthorOfPublication.latestForDiscovery | 8dab9a0d-f44a-4d2d-b9b1-7b3145162ca3 | |
relation.isProjectOfPublication | 1ffcd35c-4af7-4abe-926e-bc6aa9743877 | |
relation.isProjectOfPublication | 85f8b1e6-0236-47a6-b77b-6d8826f36004 | |
relation.isProjectOfPublication | 5dfd3f30-1de2-4516-80a8-f0bd4a06cfd0 | |
relation.isProjectOfPublication | 1a012923-2c5c-4c2f-adb8-e3c4e45d2cd6 | |
relation.isProjectOfPublication.latestForDiscovery | 1a012923-2c5c-4c2f-adb8-e3c4e45d2cd6 |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- Discovery of a new small-molecule inhibitor of p53-MDM2 interaction using a yeast-based approach.pdf
- Size:
- 1.16 MB
- Format:
- Adobe Portable Document Format
License bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- license.txt
- Size:
- 1.71 KB
- Format:
- Item-specific license agreed upon to submission
- Description: